SEMA3A and tongue squamous cell carcinoma: Objective: To investigate the association between semaphorin 3A (SEMA 3A) and its receptor neuropilin 1 (NRP1) and the clinicopathologic characteristics of patients with tongue cancer.Study Design: Forty-three tongue squamous cell carcinoma specimens were included.